1-6 of 6
Nagalakshmi Nadiminty
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells

Ramakumar Tummala, Wei Lou, Allen C. Gao, Nagalakshmi Nadiminty
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (12): 2770–2779.
https://doi.org/10.1158/1535-7163.MCT-17-0030
Published: 03 December 2017
View article titled, Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells
Open the PDF for Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer

Chengfei Liu, Cameron M. Armstrong, Wei Lou, Alan P. Lombard, Vito Cucchiara, Xinwei Gu, Joy C. Yang, Nagalakshmi Nadiminty, Chong-xian Pan, Christopher P. Evans, Allen C. Gao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (8): 1521–1530.
https://doi.org/10.1158/1535-7163.MCT-16-0912
Published: 02 August 2017
View article titled, Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer
Open the PDF for Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer

Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu, Wei Lou, Christopher P. Evans, Allen C. Gao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (8): 1884–1895.
https://doi.org/10.1158/1535-7163.MCT-14-1057
Published: 05 August 2015
View article titled, NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer
Open the PDF for NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer

Yezi Zhu, Chengfei Liu, Nagalakshmi Nadiminty, Wei Lou, Ramakumar Tummala, Christopher P. Evans, Allen C. Gao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (9): 1829–1836.
https://doi.org/10.1158/1535-7163.MCT-13-0208
Published: 05 September 2013
View article titled, Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer
Open the PDF for Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu, Joy Yang, Wei Lou, Christopher P. Evans, Allen C. Gao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1629–1637.
https://doi.org/10.1158/1535-7163.MCT-13-0027
Published: 08 August 2013
View article titled, NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants
Open the PDF for NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants in another window
Includes: Supplementary data
Journal Articles

Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer

Jae Yeon Chun, Nagalakshmi Nadiminty, Soo Ok Lee, Sergio A. Onate, Wei Lou, Allen C. Gao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 913–918.
https://doi.org/10.1158/1535-7163.MCT-05-0389
Published: 28 April 2006
View article titled, Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer
Open the PDF for Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer in another window